Checkmate Pharmaceuticals OverviewCheckmate Pharmaceuticals Net Income
Profitability analysis for CMPI.
Quarterly Net Income
-$15.89M
↓ 12.44% YoY
As of Mar 2022
Annual Net Income (TTM)
-$63.16M
↓ 46.09% YoY
Trailing 12 months ending Mar 2022
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...